Covid-19 Vaccine Confidence at One Year

A little over a year since Covid-19 vaccines became available, more than 60 percent of the world’s population has received at least one dose. But the global distribution of Covid-19 vaccines is uneven. At least 75 percent of people in the United States have received at least one dose of Covid-19 vaccine, but the same is true for just 10 percent of the population in low-income countries. As efforts to improve equity in vaccine supply and delivery advance, more countries are also now confronting the challenge of securing community trust – the final step needed to deliver shots into arms. While countries work to expand vaccine access and accelerate the uptake of vaccines, misinformation and rumors about Covid-19 vaccines crowd the information environment, politicizing vaccines, and undermining efforts to improve health security. What strategies can best equip people to make informed decisions about Covid-19 vaccines for themselves and their families? One year into the distribution of vaccines, are there still opportunities to change people’s minds?

Please join the CSIS-LSHTM High-Level Panel on Vaccine Confidence and Misinformation on Friday, February 4, from 10:00am to 11:00am EST to reflect on what has been learned over the first year of the Covid-19 vaccine rollout, and what more can be done to strengthen vaccine confidence in the United States and internationally. The session will begin with a keynote presentation from Heidi J. Larson, professor of anthropology, risk, and decision science, and director of the Vaccine Confidence Project™ at the London School of Hygiene & Tropical Medicine. Her presentation will be followed by a panel discussion featuring Mollyann Brodie, executive vice president, COO, and executive director of public opinion and survey research at the Kaiser Family Foundation; James A. Lewis, senior vice president and director of the CSIS Strategic Technologies Program; and J. Stephen Morrison, senior vice president and director of the CSIS Global Health Policy Center. Katherine E. Bliss, senior fellow and director of immunizations and health systems resilience at the CSIS Global Health Policy Center, will moderate the discussion.

The panel’s work is supported by a grant from the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the foundation.